Arthur & Sonia Labatts Brain Tumor Center, Hospital for Sick Children, University of Toronto, Toronto, Canada M5G 2G4.
J Oncol. 2010;2010:659231. doi: 10.1155/2010/659231. Epub 2010 May 11.
Angiopoietins and Tie2 are angiogenic-specific ligand and receptor complex that have been shown to play a critical role in tumor angiogenesis. Angiopoietin-2 (Ang2) is one of four ligands for receptor Tie2 and it is the naturally occurring antagonist to Tie2, inhibiting the action of Angiopoietin-1 (Ang1). Over the last decade, significant research has focused on elucidating the role of Ang2 in cancer biology and its exact role in tumor angiogenesis remains elusive. In this study we have focused on establishing the role of Ang2 in angiogenesis of malignant astrocytomas. We have demonstrated that Ang2 significantly enhances the vascular growth of malignant astrocytomas and constant upregulation of Ang2 throughout all phases of tumor growth generates abnormal vascular structures that are not typically seen in human astrocytomas, suggesting that Ang2 plays a tumor stage-dependent role and is not a consistently elevated throughout all growth stages of malignant astroctyomas.
血管生成素和 Tie2 是血管生成特异性配体和受体复合物,已被证明在肿瘤血管生成中发挥关键作用。血管生成素-2(Ang2)是受体 Tie2 的四个配体之一,是 Tie2 的天然拮抗剂,抑制血管生成素-1(Ang1)的作用。在过去的十年中,大量的研究集中在阐明 Ang2 在癌症生物学中的作用,但其在肿瘤血管生成中的确切作用仍不清楚。在这项研究中,我们专注于确定 Ang2 在恶性星形细胞瘤血管生成中的作用。我们已经证明,Ang2 显著增强了恶性星形细胞瘤的血管生长,并且 Ang2 的持续上调贯穿肿瘤生长的所有阶段,产生了通常在人类星形细胞瘤中看不到的异常血管结构,这表明 Ang2 发挥了肿瘤阶段依赖性的作用,并且不是在恶性星形细胞瘤的所有生长阶段都持续升高。